AGM and Trading Update

RNS Number:2191B
Genosis PLC
31 July 2007




For Immediate Release                                               31 July 2007



                                  GENOSIS PLC


                             ANNUAL GENERAL MEETING

                                      AND

                                 TRADING UPDATE


The Annual General Meeting was held today for Genosis PLC (AIM: GNOS) the
company specialising in consumer products for reproductive health. After the
formal proceedings of the meeting were completed, in which all resolutions were
passed, Dr Joe Blaker, the Chairman, provided the following trading update to
shareholders.


Genosis is pleased to announce that sales in the first six months to June 2007
were #503,000, more than two and a half times sales of the same period last
year. This growth in sales is due to two key factors, the launch of the Fertell
ovarian reserve test in the UK market and the launch on 4th June 2007 of the
Fertell couples test into the US market.


As previously announced, the US drug store chains CVS and Longs Drugs are
distributing the Fertell couples test throughout the US. Initial stocking orders
amounted to 7,250 units and, as at 30th June 2007, the distributors had ordered
a further 3,400 units. Web sales in the US for the period to 30th June 2007 were
approximately 870 units.


The launch of the Fertell test in the US was well received in the press and
media with as many as 24 of the 25 National TV networks mentioning the product.
Of particular note was Fertell being featured in a prime time slot on ABC's
network news programme "Good Morning America".


Whilst the ordering levels in June were below expectations, the ongoing PR
campaign and the July start of the print media programme should result in
growing orders of the product throughout the second half of the year and beyond.
Sales in the UK continue in line with expectations through the Company's
exclusive agreement with Alliance Boots.


Genosis announced recently the successful completion of a secondary funding
round raising #2.3 million (gross) which was supported by existing and new
investors. This has strengthened the Group's balance sheet and will enable
Genosis to increase its marketing activities in the US over the next 12 months.
As at 30 June 2007 Genosis had cash in hand of #3.2 million.


For further details, please contact:

Genosis PLC                 Paul Bateman, CEO            +44 (0)1483774058
                            Jonathan Pockson, CFO
Buchanan Communications     Lisa Baderoon                +44 (0)2074665000
                            Rebecca Skye Dietrich
Evolution Securities        Tim Worlledge                +44 (0)2070714300
                            Bobbie Hilliam




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCSDUFLFSWSEEW

Genosis (LSE:GNOS)
過去株価チャート
から 5 2024 まで 6 2024